Development of targeted alpha particle therapy for solid tumors.

Tafreshi, Narges K., Doligalski, Michael L., Tichacek, Christopher J., Pandya, Darpan N., Budzevich, Mikalai M., El-Haddad, Ghassan, Khushalani, Nikhil I., Moros, Eduardo G., McLaughlin, Mark L., Wadas, Thaddeus J., Morse, David L.·2019·Molecules
DOI 10.3390/molecules24234314

Cited by (156)

Items 101–156 of 156

  1. Alpha particle microdosimetry calculations using a shallow neural network
    Peter Wagstaff, Pablo Mínguez Gabiña, Ricardo Mínguez, John C. Roeske · 2022 · Physics in Medicine and Biology
  2. 212Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation
    Satyendra Kumar Singh, Nathan Kauffman, Isabelle Maria Lynch, Zeynep Meral Kunt, Kurt R. Zinn, Dalen Agnew, Jinda Fan · 2025 · Journal of Nuclear Medicine
  3. [ 225 Ac]Ac-Macropa-PEG 4 -HEA125 for Targeted α Therapy in Epithelial Cell Adhesion Molecule-Positive Tumors: Conjugation, Radiolabeling, and Efficacy
    Syed Qaiser Shah, Saba Shirin · 2025 · Cancer Biotherapy and Radiopharmaceuticals
  4. Microdosimetric analysis of proton boron capture therapy using microdosimetric kinetic model
    MD ABDUR RAHIM, Tatsuhiko Sato, Hiroshi Fukuda, Mehrdad Shahmohammadi Beni, Hiroshi Watabe · 2026 · Biomedical Physics & Engineering Express
  5. Radiation-emitting electronic products
    Nicholas Vollano · 2023 · Elsevier eBooks
  6. Targeted Alpha Therapy in Cancer Management: Therapeutic Prospects of Nuclear Medicine in Oncology
    Sipho Mdanda, Amanda Henrietta Mdlophane, Honest Ndlovu, Keamogetswe Ramonaheng, Milani Qebetu, Johncy Mahapane, Mankgopo Kgatle, Yonwaba V. Mzizi, Reabetswe Sebatana, Zamani E. D. Cele et al. · 2023 · Interdisciplinary cancer research
  7. Assessment of DNA damage in healthcare workers occupationally exposed to low doses of ionizing radiation in the comet assay: Meta-analysis
    Yusra Zabarmawi · 2024 · Journal of Radiation Research and Applied Sciences
  8. In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy
    Gabriele Birindelli, Miloš Drobnjaković, Volker Morath, Katja Steiger, Calogero D’Alessandria, Eleni Gourni, Ali Afshar‐Oromieh, Wolfgang Weber, Axel Rominger, Matthias Eiber et al. · 2021 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  9. A projection-domain low-count quantitative SPECT method for alpha-particle emitting radiopharmaceutical therapy
    Zekun Li, Nadia Benabdallah, Diane S. Abou, Brian Christopher Baumann, Farrokh Dehdashti, Ballard, David H., Liu, Jonathan, Udayabhanu M. Jammalamadaka, Richard A. Laforest, Richard L. Wahl et al. · 2021 · arXiv (Cornell University)
  10. Voxel based 211At dosimetry using CT and SPECT data with equivalent source term optimization
    Jinyang Li, Xingchen Zhou, Hui Wang, Jun-Liang Du, Wenming Zhou · 2025 · Journal of Radioanalytical and Nuclear Chemistry
  11. Combination Image-Guided and Antibody-Targeted α-Therapy Before Targeted Immunotherapy for Treatment of Solid Tumors
    Maciej Kujawski, Eric Chekwube Aniogo, Patty W. Wong, Susanta Kumar Hui, Hemendra Ghimire, Erasmus Kofi Poku, Paul J. Yazaki, Jeffrey Y.C. Wong, John E. Shively · 2025 · Journal of Nuclear Medicine
  12. Synthesis and quality control of [225Ac][Ac-DOTATATE]: feasibility of the targeted alpha therapy (TAT) in conventional clinical pharmacy equipped for Tc-99 m in Pakistan
    Shakera Khatoon Rizvi, Amna Javed, Qaiser Khan · 2025 · Journal of Radioanalytical and Nuclear Chemistry
  13. Gallium-infused nanomaterials for cancer theranostics and biosensing: Advancement and translation outlooks
    Suraj Kumar, Sathvik Belagodu Sridhar, Javedh Shareef, Tarun Wadhwa, Dhanalekshmi Unnikrishnan Meenakshi, Rishabha Malviya · 2026 · Journal of Trace Elements and Minerals
  14. Preclinical Evaluation of [ 225 Ac]Ac–Sibrotuzumab Employing a PEG 4 –Macropa Site‐Specific Chelation Strategy for Targeted Ablation of Cancer‐Associated Fibroblasts in Desmoplastic Tumors
    Syed Qaiser Shah, Ralph Santos‐Oliveira, Madeeha Shabnam, DeryaIlem-Ozdemir · 2026 · Journal of Labelled Compounds and Radiopharmaceuticals
  15. Local Production of the Alpha-Emitting Radioi-sotope Actinium 225 with Low Impurities for Targeted Alpha Ther-apy by a Compact Neutron Generator System
    M. Martellini, K. N. Leung, Giuseppe Gherardi, Lidia Falzone · 2023 · Medical Research Archives
  16. A Methodical Review of Intranasal Delivery of Nanocarriers for the Treatment of Glioblastoma: An Emerging Therapeutic Option
    Pankaj Popli, Monika, Pragi, Varun Kumar, Deepanshu Sharma, Shrikant, Shabnam Kumari, Deepak Garg · 2024 · Current Drug Therapy
  17. LAT1-Targeted Alpha Therapy Using 211At-AAMT for Bone and Soft Tissue Sarcomas
    Haruna Takami, Yoshinori Imura, Hidetatsu Outani, Sho Nakai, Akitomo Inoue, Yuki Kotani, Seiji Okada, Kazuko Kaneda‐Nakashima · 2025 · International Journal of Molecular Sciences
  18. Patient organ doses from radionuclide therapy with 225Ac-DOTATATE
    L. Afanasjev, Л. А. Чипига, Холопова Екатерина Дмитриевна, Nikolay Nikolaevich Potrakhov · 2023 · AIP conference proceedings
  19. Antibodies and antibody constructs as radiopharmaceuticals
    Annemarie Kip, Sandra Heskamp · 2021 · Elsevier eBooks
  20. Cytogenetic study of dental diagnostic x-ray workers
    Asrar Kamil Salman, Sada Jasim Abdulameer · 2022 · International Journal of Health Sciences
  21. Cancer suppression by ferroptosis and its role in digestive system tumors
    Jiajia Li, Xuanping Xia, Limin Wu, Zheng Gang Zhu, Yu-Ning Shi, Xu‐Chao Zhang, Yu-Shan Xia, Guangrong Lu · 2022 · World Chinese Journal of Digestology
  22. A Collimatorless Detector for In vivo 225Ac Tomography: a Feasibility Study
    J. Caravaca Rodríguez, Yifan Zheng, Yoonsuk Huh, Grant T. Gullberg, Youngho Seo · 2021 · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC)
  23. Metal Complexes as the Means or the End of Targeted Delivery for Unmet Needs
    Trevor W. Hambley · 2022 · Methods and principles in medicinal chemistry
  24. Development of Next-Generation Antibody Therapeutics Using DDS and Molecular Imaging
    Masahiro Yasunaga · 2023 · Springer eBooks
  25. Data from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
    Vandana Batra, Minu Samanta, Mehran Makvandi, David Groff, Paul Martorano, Jimmy Elias, Pietro Ranieri, Matthew Tsang, Catherine Hou, Yimei Li et al. · 2023
  26. Data from Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
    Anil P. Bidkar, Sinan Wang, Kondapa Naidu Bobba, Emily Chan, Scott M. Bidlingmaier, Emily A. Egusa, Robin Peter, Umama Ali, Niranjan Meher, Anju Wadhwa et al. · 2023
  27. Data from Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
    Anil P. Bidkar, Sinan Wang, Kondapa Naidu Bobba, Emily Chan, Scott M. Bidlingmaier, Emily A. Egusa, Robin Peter, Umama Ali, Niranjan Meher, Anju Wadhwa et al. · 2023
  28. Development of 225 Ac-doped Biocompatible Nanoparticles for Targeted Alpha Therapy
    Miguel Toro-González, Ngozi D. Akingbesote, Amber N. Bible, Brian Sanders, Alexander S. Ivanov, Santa Jansone‐Popova, Ilja Popovs, Paul D. Benny, Rachel J. Perry, Sandra M. Davern · 2024 · Research Square
  29. Radioimmunotherapy-An Overview
    Komal Rana, Sibi Oommen, Sanjay Bharati · 2024 · Springer eBooks
  30. Accurate Replication of a Gamma Decay Cascade Using Mechanical Adjustable Arm
    Shangcong Cheng, Bruce Pierson, Marek Flaska · 2024 · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC)
  31. Calculation of alpha particle single-event spectra using a neural network
    Layth Alkhani, Jason Luce, Pablo Mínguez Gabiña, John C. Roeske · 2024 · Frontiers in Oncology
  32. Unmet Medical Needs and the Development of Next-Generation Antibody Therapeutics
    Masahiro Yasunaga · 2025 · Drug Delivery System
  33. Helium 4He nuclei based radiotherapy
    Natalia Knake, Rafal Prokopowicz, Michał Aleksander Gryziński, Janusz Kocik · 2025 · Applied Radiation and Isotopes
  34. Selected structural highlights of f-element compounds
    Attila Kovács · 2025 · Structural Chemistry
  35. Development of Next-Generation Antibody Therapeutics Using DDS and Molecular Imaging
    Masahiro Yasunaga · 2025 · Springer eBooks
  36. Metal grafted graphene-based nanomaterials towards cancer theranostic efficacy
    Prashant H. Gohil, Gopal Avashthi · 2025 · Exploration of Targeted Anti-tumor Therapy
  37. Additional file 1 of Development of 225Ac-doped biocompatible nanoparticles for targeted alpha therapy
    Miguel Toro-González, Ngozi D. Akingbesote, Bible, Amber, Debjani Pal, Brian Sanders, Alexander S. Ivanov, Santa Jansone‐Popova, Ilja Popovs, Paul D. Benny, Rachel J. Perry et al. · 2024 · Figshare
  38. Additional file 1 of First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs
    Maryana Handula, Savanne Beekman, Konijnenberg, Mark, Debra C. Stuurman, de Ridder, Corrina, Bruchertseifer, Frank, Morgenstern, Alfred, Antonia G. Denkova, Erik de Blois, Yann Seimbille · 2023 · Figshare
  39. Additional file 1 of Core–shell structured gold nanoparticles as carrier for 166Dy/166Ho in vivo generator
    Runze Wang, Bernard Ponsard, Hubert Th. Wolterbeek, Antonia G. Denkova · 2022 · Figshare
  40. [225Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer
    Anjong Florence Tikum, Dede Api Fon, Fabrice Ngoh Njotu, Nikita W. Henning, Emmanuel Nwangele, Hanan Babeker, Jessica Pougoue Ketchemen, Alireza Doroudi, Maruti Uppalapati, Humphrey Fonge · 2026 · Breast Cancer Research
  41. Applicability of simplified alpha spectroscopy for radionuclidic purity tests at 225Ac production sites
    Mihei Yuma, Kotaro Tani, Jun Ichinose, Kotaro Nagatsu, Masayuki Naito, Masahiro Fukushi, Osamu Kurihara, Kazumasa Inoue · 2026 · Radiation Protection Dosimetry
  42. Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases
    Cynthia Choi, Adedamola O. Adeniyi, Ohyun Kwon, Jen Zaborek, Caroline P. Kerr, Hansel Comas Rojas, Malick Bio Idrissou, Carolina A. Ferreira, Paul A. Clark, Won Jong Jin et al. · 2026 · Precision Oncology
  43. A Scoping Review of the Challenges and Future Perspectives in the Use of Alpha-Emitters for Metastatic Ovarian Cancer
    Lu Lucy Xu, Satyendra Kumar Singh, Nelli Gaspar, Jinda Fan, Benjamin L. Viglianti, Kurt R. Zinn · 2026 · Molecules
  44. Method Development and Validation of High-Resolution Gamma Spectrometry for Accurate Radionuclidic Purity Assessment of Actinium-225
    Raquel Espino López, Candelaria Candy Quiroga Castro, Mehdi Boudjemeline, Luis Michel A Martinez · 2026 · SSRN Electronic Journal
  45. Monte Carlo modeling of targeted radionuclide therapy of micrometastases
    Mario Alcocer‐Ávila · 2021 · theses.fr (ABES)
  46. The influence of melanocortin-1 receptor gene polymorphisms on the clinical-biological tumor profile and prognosis in patients with cutaneous melanoma
    Ekaterina N. Eremina, R. A. Zukov · 2026 · Siberian Journal of Oncology
  47. Atomic degradation: chemical design strategies and immunotherapeutic mechanisms of radio-PROTACs
    Tuğba Ören Varol, Mehmet Varol · 2026 · Annals of Nuclear Medicine
  48. Engineering intrinsically radiolabeled nanoparticles for imaging and therapy: a decade of design strategies and insights
    Sanchita Ghosh, Rubel Chakravarty · 2026 · RSC Advances
  49. Development and validation of a gamma spectrometry method for actinium-225 quantification and routine radionuclidic purity monitoring
    Raquel Espino López, Candelaria Candy Quiroga Castro, Mehdi Boudjemeline, Luis Michel A Martinez · 2026 · Applied Radiation and Isotopes
  50. Monte Carlo simulations of 241Amα‐particle energy distribution, LET distribution, and absorbed dose in a cell layer
    Martyna Araszkiewicz, Katarzyna Tymińska, Urszula Kaźmierczak, Patrycja Chuchała, Jarosław Grzyb, Patrycja Kamińska, R. Kwiatkowski, Marta Maleszewska, A. Malinowska, Kamila Maliszewska‐Olejniczak et al. · 2026 · Medical Physics
  51. Linking In Vivo Imaging to Therapeutic Outcome with 131I, 177Lu, 188Re Nanoparticles
    Yu. А. Finogenova, Alexey Lipengolts, Olga Klementyeva, K. E. Shpakova, V. А. Skribitsky, Е. Yu. Grigorieva · 2026 · International Journal of Molecular Sciences
  52. Targeted Alpha Therapy as a Multiscale Design Problem: From Radioactive Decay to Therapeutic Outcome
    Isidora Lazić, Aljoša Stanković, Nemanja Todorović, Sofija Forkapić, Mladena N. Lalic-Popovic · 2026 · Pharmaceuticals
  53. Neutron spectrum optimization for reactor-based production of Ac-225 and impurity control
    Lv Guo, Qingquan Pan, Xiaojing Liu · 2026 · Nuclear Engineering and Technology
  54. Clinical Imaging of 225 Ac in a PET Scanner via Time-of-Flight Cascade γ-Ray Imaging
    J. Caravaca Rodríguez, Youngho Seo, Jorge Cabello, Stefan B. Siegel, Robert R. Flavell, Thomas A. Hope · 2026 · Journal of Nuclear Medicine
  55. Proton boron capture therapy and neutron capture enhanced proton therapy: a critical review of investigational approaches in proton therapy
    A. F. Abdul Rahim, Hiroshi Watabe · 2026 · Radiological Physics and Technology
  56. Targeted radioligand therapy in oncology: clinical development across targets and platforms
    Jiaxin An, Xiaolei Meng, Lara Hathout, Ronald D. Ennis, Xinxin Zhang, Ning Jeff Yue, Matthew Pierre Deek, Salma K. Jabbour · 2026 · Frontiers in Oncology